MICALL2 and colorectal carcinoma: The expression levels of MICALL2 were up-regulated in colorectal cancer tissues (Fig. 1A) by using RNAseq data from The Cancer Genome Atlas (TCGA), and Kaplan–Meier survival curve analysis demonstrated that CRC patients with higher MICALL2 protein expression had poorer overall survival rate (Fig. 1B).